ABEONA THERAPEUTICS INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Abeona Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Abeona Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.32M, a 42.7% increase year-over-year.
  • Abeona Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.94M, a 87.9% increase year-over-year.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.77M, a 56.3% increase from 2022.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.05M, a 65.8% decline from 2021.
  • Abeona Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.92M, a 52.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.94M $1.32M +$396K +42.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $5.54M $1.55M +$776K +101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.77M $1.51M +$681K +81.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $4.09M $1.56M +$925K +146% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.16M $927K +$203K +28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $2.96M $770K -$92K -10.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.05M $833K -$1.17M -58.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $4.22M $632K -$1.91M -75.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $6.12M $724K -$1.7M -70.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $7.83M $862K -$1.09M -55.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.92M $2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $2.54M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.43M +$850K +53.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.95M +$694K +55.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q2 2020 $6.39M $1.58M -$100K -5.96% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $6.49M $1.26M -$847K -40.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $7.34M $1.73M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 $1.83M -$673K -26.9% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.68M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.1M +$203K +10.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 $2.5M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q1 2018 $1.9M +$408K +27.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $1.49M -$100K -6.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $5.74M $1.59M +$1.37M +611% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $4.37M $1.79M +$1.64M +1125% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $2.73M $1.45M +$1.28M +744% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $1.45M $904K +$712K +371% Apr 1, 2015 Jun 30, 2015 10-Q/A 2015-08-14
Q1 2015 $734K $224K -$571K -71.8% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $1.31M $146K +$61K +71.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $1.24M $172K +$146K +562% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $1.1M $192K -$59K -23.5% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-14
Q1 2014 $1.16M $795K +$718K +932% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $439K $85K +$2K +2.41% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $437K $26K -$59K -69.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $496K $251K +$143K +132% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $353K $77K -$37K -32.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $390K $83K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 $85K -$259K -75.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $108K -$134K -55.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $114K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $344K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $242K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.